Determining molecular binding sites on human serum albumin by displacement of oleic acid

Analytical Biochemistry

Volumn 347, Issue 2, 2005, Pages 297-302

  Sarver, Ronald W ^a   Gao, Hua ^b   Tian, Fang ^c  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Albumin; Binding sites; HSQC NMR

Indexed keywords

CRYSTAL STRUCTURE; DRUG PRODUCTS; LIGANDS; MOLECULES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLEIC ACID; QUANTUM THEORY;

ALBUMIN; DIRECT OBSERVATIONS; DRUG BINDING SITES; HETERONUCLEAR SINGLE-QUANTUM COHERENCES; HSQC NMR; HUMAN SERUM ALBUMINS; MOLECULAR BINDING; STRUCTURE ACTIVITY RELATIONSHIPS;

BINDING SITES;

IBUPROFEN; WARFARIN;

ARTICLE; ATOMIC PARTICLE; BINDING SITE; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTUM CHEMISTRY; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

EID: 27944474259     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2005.09.039     Document Type: Article

References (31)

1. T. Peters All About Albumin: Biochemistry, Genetics, and Medical Application 1996 Academic Press San Diego
2. U. Kragh-Hansen, V.T.G. Chuang, and M. Otagiri Practical aspects of the ligand-binding and enzymatic properties of human serum albumin [review] Biol. Pharm. Bull. 25 2002 695 704
3. K. Yamasaki, T. Maruyama, U. Kragh-Hansen, and M. Otagiri Characterization of site I on human serum albumin: Concept about the structure of a drug binding site Biochim. Biophys. Acta 1295 1996 147 157
4. K. Yamasaki, T. Maruyama, K. Yoshimoto, Y. Tsutsumi, R. Narazaki, A. Fukuhara, U. Kragh-Hansen, and M. Otagiri Interactive binding to the two principal ligand sites of human serum albumin: Effect of the neutral-to-base transition Biochim. Biophys. Acta 1432 1999 313 323
5. A.A. Bhattacharya, S. Curry, and N. Franks Binding of the general anesthetics propofol and halothane to human serum albumin J. Biol. Chem. 275 2000 38731 38738
6. B.W. Dubois, and A.S. Evers 19F-NMR spin-spin relaxation (T2) method for characterizing volatile anesthetic binding to proteins: analysis of isoflurane binding to serum albumin Biochemistry 31 1992 7069 7076
7. I. Petitpas, A.A. Bhattacharya, S. Twine, M. East, and S. Curry Crystal structure analysis of warfarin binding to human serum albumin J. Biol. Chem. 276 2001 22804 22809
8. J.D. Ashbrook, A.A. Spector, E.C. Santos, and J.E. Fletcher Long chain fatty acid binding to human plasma albumin J. Biol. Chem. 250 1975 2333 2338
9. H. Vorum, and B. Honore Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy J. Pharmacy Pharmacol. 48 1996 870 875
10. H. Vorum, K. Fisker, and B. Honore Palmitate and stearate binding to human serum albumin: determination of relative binding constants J. Peptide Res. 49 1997 347 354
11. N.A. Kratochwil, W. Huber, F. Muller, M. Kansy, and P.R. Gerber Predicting plasma protein binding of drugs: a new approach [review] Biochem. Pharmacol. 64 2002 1355 1374
12. G. Sudlow, D.J. Birkett, and D.N. Wade The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol. 11 1975 824 832
13. D.E. Epps, T.J. Raub, and F.J. Kezdy A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin Anal. Biochem. 227 1995 342 350
14. D.E. Epps, T.J. Raub, V. Caiolfa, A. Chiari, and M. Zamai Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein J. Pharmacy Pharmacol. 51 1999 41 48
15. S. Wanwimolruk, D.J. Birkett, and P.M. Brooks Structural requirements for drug binding to site II on human serum albumin Mol. Pharmacol. 24 1983 458 463
16. G. Sudlow, D.J. Birkett, and D.N. Wade Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin Mol. Pharmacol. 9 1973 649 657
17. G. Sudlow, D.J. Birkett, and D.N. Wade Spectroscopic techniques in the study of protein binding: a fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol Clin. Exp. Pharmacol. Physiol. 2 1975 129 140
18. G. Sudlow, D.J. Birkett, and D.N. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 1976 1052 1061
19. W.E. Muller The use of 8-anilino-1-naphthalenesulfonic acid as a reporter group molecule for circular dichroism and fluorescence measurements: the effect of stearic acid and sodium dodecyl sulfate on the conformation of bovine and human serum albumin Hoppe Seylers Z. Physiol. Chem. 357 1976 1487 1494
20. C. Dalvit, M. Flocco, B.J. Stockman, and M. Veronesi Competition binding experiments for rapidly ranking lead molecules for their binding affinity to human serum albumin Comb. Chem. High Throughput Screen. 5 2002 645 650
21. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
22. I. Petitpas, T. Grune, A.A. Bhattacharya, and S. Curry Crystal structures of human serum albumin complexed with monosaturated and polyunsaturated fatty acids J. Mol. Biol. 314 2001 955 960
23. A.A. Bhattacharya, T. Grune, and S. Curry Crystallographic analysis reveals common models of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol. 303 2000 721 732
24. C. Curry, H. Mandelkow, P. Brick, and N. Franks Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Biol. 5 1998 827 835
25. D.P. Cistola, D.M. Small, and J.A. Hamilton Carbon-13 NMR studies of saturated fatty acids bound to bovine serum albumin: I. The filling of individual fatty acid binding sites J. Biol. Chem. 262 1987 10971 10979
26. D.P. Cistola, D.M. Small, and J.A. Hamilton Carbon-13 NMR studies of saturated fatty acids bound to bovine serum albumin: II. Electrostatic interactions in individual fatty acid binding sites J. Biol. Chem. 262 1987 10980 10985
27. J.A. Hamilton, S. Era, S.P. Bhamidipati, and R.G. Reed Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin Proc. Natl. Acad. Sci. USA 88 1991 2051 2054
28. J.A. Hamilton, D.P. Cistola, J.D. Morrisett, J.T. Sparrow, and D.M. Small Interactions of myristic acid with bovine serum albumin Proc. Natl. Acad. Sci. USA 81 1984 3718 3722
29. G.V. Richieri, A. Anel, and A.M. Kleinfeld Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB Biochemistry 32 1993 7574 7580
30. H.Y. Mao, P.J. Hajduk, R. Craig, R. Bell, T. Borre, and S.W. Fesik Rational design of diflunisal analogues with reduced affinity for human serum albumin J. Am. Chem. Soc. 123 2001 10429 10435
31. R.S. Luo, M.L. Liu, and X.A. Mao NMR diffusion and relaxation study on ibuprofen-HSA interaction Appl. Spectrosc. 53 1999 776 779